B
Berkeley Eye Center | Sugar Land, TX
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
RGN-259
Parent organization
This site is a part of Berkeley Eye Center
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 6 total trials
The objective of this study is to compare the safety and efficacy of RGN-259 to placebo for the treatment of Neurotrophic Keratopathy (NK)
Enrolling
Neurotrophic Keratopathy
Drug: Placebo
Drug: RGN-259
A prospective, multicenter, randomized, single-masked, post-market clinical trial comparing cataract surgery in conjunction with ab-interno canalopla...
Enrolling
Primary Open Angle Glaucoma
Device: Cataract surgery combined with ab-interno canaloplasty utililzing the iTrack Advance canaloplasty device
Procedure: Cataract surgery
Trial sponsors
C
N
R
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems